Frailty is a geriatric syndrome characterised by a vulnerability status associated with declining function of multiple physiological systems and loss of physiological reserves. Two main models of frailty have been advanced: the phenotypic model (primary frailty) or deficits accumulation model (secondary frailty), and different instruments have been proposed and validated to measure frailty. However measured, frailty correlates to medical outcomes in the elderly, and has been shown to have prognostic value for patients in different clinical settings, such as in patients with coronary artery disease, after cardiac surgery or transvalvular aortic valve replacement, in patients with chronic heart failure or after left ventricular assist device implantation. The prevalence, clinical and prognostic relevance of frailty in a cardiac rehabilitation setting has not yet been well characterised, despite the increasing frequency of elderly patients in cardiac rehabilitation, where frailty is likely to influence the onset, type and intensity of the exercise training programme and the design of tailored rehabilitative interventions for these patients. Therefore, we need to start looking for frailty in elderly patients entering cardiac rehabilitation programmes and become more familiar with some of the tools to recognise and evaluate the severity of this condition. Furthermore, we need to better understand whether exercise-based cardiac rehabilitation may change the course and the prognosis of frailty in cardiovascular patients.
Introduction
We belong to an ageing world where people are living longer. In 2030, progressive population ageing will lead to an increase in the proportion of people aged over 65 years from 17.4% to 25.6%, and the population of elderly people will almost double in Europe from 87.5 million in 2010 to 152.6 million in 2060. 1 Progressive ageing is associated with geriatric syndromes (particularly frailty) that pose a severe burden on health systems. Therefore, there is a need to understand these syndromes better, with particular attention to the relevance of frailty in the context of care of older cardiac patients, including cardiac rehabilitation (CR).
Frailty and its relationship with disability and comorbidity
Frailty is characterised by impairment in many domains (e.g. physical, psychological and social) with consequent effects on mortality, hospitalisation, dependence, disability and significant healthcare cost. 2 Although varying definitions exist, there is a common thread in that frailty is a dynamic age-related vulnerability 3 characterised by declining function, associated with a loss of physiological reserves of multiple organs or systems, and an increased risk of negative outcomes, such as institutionalisation and death. 4, 5 The pathophysiological mechanisms underlying the development or progress of a frailty status are multifactorial, and include inflammatory mechanisms, the hypothalamichypophysary axis, and anabolic-catabolic hormone imbalance. 5 Studies show that frailty, independently of how it is measured, is significantly and independently correlated to medical outcomes. 6, 7 Despite the relevance of frailty as a prognostic indicator, uncertainty remains regarding its definition, its measurement, the feasibility of its measurement in clinical practice and whether such measurements can be influenced by interventions or describe the progress or deterioration of health status. This is particularly true in the CR setting, where the increasing age of patients admitted to CR poses problems in individualising models of clinical evaluation and interventions.
The extent of frailty is not determined purely by the magnitude and frequency of comorbidity or disability, as patients with the same comorbidity or disability may present with different degrees of frailty or no frailty at all. On the other hand, a patient may be frail with few comorbidities or disabilities. 8 Based on data from the Cardiovascular Health Study, about 25% of older patients show signs of frailty without either multiple comorbidities or disabilities. 9 Disability may be a consequence of frailty but, alternatively, disability may be closely linked to the development or worsening of frailty status; in particular, so-called primary frailty, described in older patients without overt pathological conditions, and can lead to diseases or disability and to secondary frailty that in turn may worsen the phenotypic presentation of frailty. 10 The recognition and measurement of frailty and the possibility of modifying this status are important issues within and beyond modern geriatric medicine.
Frailty models
Two main models of frailty have been proposed. The phenotype model proposed by Fried et al. views frailty as a biological syndrome resulting from cumulative decline across multiple physiological systems. 4 The model advanced by Rockwood et al. views frailty as a multidimensional risk state that can be measured more by the quantity than by the nature of health problems. [11] [12] [13] Primary frailty model: the phenotype model. According to Fried et al., a wealth of epidemiological or observational studies has described the presence of frailty in the general elderly population (physiological ageing). In this environment frailty has been defined as 'primary frailty', a phenotypic presentation involving decline in physical functioning and psychological status, without taking into consideration associated diseases or pathological conditions. Fried's phenotype frailty index 4 (PFI) has been widely adopted: it was derived from an analysis of five health domains: nutrition; physical exhaustion; low energy expenditure (or inactivity status); mobility; and muscular strength ( Table 1) . Deterioration of each of these domains was scored as 1 if present or 0 if absent, giving a potential score spanning from 0 to 5. The phenotype model classified three categories: robust (no deterioration); pre-frail (one or two function deterioration); or frail (three or more function deterioration). This categorisation was independently correlated with outcomes, such as survival, falls, disability and institutionalisation. 4 Secondary frailty model: accumulation of deficit model. The conceptualisation of frailty proposed by Rockwood et al. considers the accumulation of multiple deficits such as symptoms, signs, disabilities, pathological conditions and abnormal laboratory values (secondary frailty). [11] [12] [13] [14] In this model, a frailty index (FI) was measured as deficit accumulation (Table 2) . Each deficit can be coded as binary (1 or 0) or ordinal (0, 0.5, 1). This FI is the sum of the deficit values divided by the total number of deficits listed (e.g. 10 deficits present out of 40 gives a FI ratio of 10/40 ¼ 0.25) and is significantly correlated with outcomes; for example, with each unit increase the hazard rate for mortality increases by 4%. 15 Frailty indices adopting the deficit accumulation model can be derived from different numbers and types of variables, provided certain criteria are fulfilled. 14 The number of deficits, rather than a single deficit, is related to adverse outcomes, as the final number reflects a global measure of vulnerability. A patient with a score of less than 0.2 would be considered not frail, an increasing score indicates an increased level of frailty. In order for a FI to be able to capture sufficient features or risk factors for frailty, it should include at least 40 items, covering several health domains, such as physical, cognitive, psychological and social. 14 It is important to note that frailty increase parallels ageing, independently of baseline frailty, and evaluation of interventions to reduce frailty must take into consideration a natural physiological increase in frailty with age.
Frailty assessment
Assessing instruments. An important issue in the clinical environment, and particularly in primary care, is that the measurement of frailty based on either the phenotypic or deficit accumulation model may be complex and time consuming. There are, however, alternative instruments to apply in clinical practice for screening and evaluating frailty in the general population (Table 3) . Some follow the phenotypic model, [16] [17] [18] [19] others consist of administered or self-administered questionnaires, 20, 21 and some require clinical evaluation 22 or task performance and measurement such as the Edmonton frailty scale (EFS). 23 Some scales are designed to be screening instruments 18 and others to be more multifaceted tools requiring comprehensive geriatric assessment (CGA). 24 They are designed for use with different groups of individuals, and differ in their feasibility and prognostic ability.
Despite these differences, all scales were predictive of all-cause mortality or of relevant elderly outcomes, in most cases independently from other prognostic indices. A recent comparison of these scales in the SHARE survey 25 showed some differences in their prognostic predictive ability. Receiver operating characteristic (ROC) curves showed that FI derived from the deficit accumulation model, FI derived from CGA (FI-CGA) and EFS performed slightly better than other scales.
As CGA, consisting of a multidimensional assessment of several health domains, is the cornerstone of modern geriatric care, 26 FI-CGA may be considered as one of the best models to measure frailty. The FI-CGA, validated in the Canadian Study of Health and Aging (CSHA), a large population-based study, 24-27 explored 10 domains, assigning a score to each domain and constructing a frailty categorisation: mild (FI-GCA 0-7), moderate (FI-CGA 7-13) and severe (FI-CGA > 13) frailty. 24 The same data from CGA can be analysed by counting the deficit according to the deficit accumulation model, 3 and both types of measurements have been correlated to outcome. 27 Extensive reports in the literature have shown that frailty can indeed be measured with relative ease even in hospital settings, for patients in general medical wards, 6,7,28-31 geriatric units, 32, 33 survivors of intensive care units or emergency departments, 34, 35 including critical oncological 36 or dialysed patients 37 (Table 4 ). In these settings, frailty has been assessed by a variety of tools including the FI-CGA instrument, 28, 30 the CSHA clinical frailty scale 6, 7, 31, 34, 37 and the phenotypic model. 29, 35, 36 Frailty varied from 20% to 82%, according to the scale and the population examined.
A direct comparison among some of these scales in hospitalised patients aged over 65 years was reported by Pilotto et al., who described an innovative frailty instrument based on a modified CGA (CGA-based multidimensional prognostic index -MPI). 38 The MPI integrated data from eight domains such as 
Value of frailty instruments in measuring outcome
Frailty depends on several interrelated factors and can change over time. As frailty is a dynamic process influenced by progressive aging, 39, 40 it is uncertain whether it can be used as an outcome measure of an intervention. 41 Therefore, an evaluative outcome instrument to measure frailty with reliable clinimetric properties is needed. 9 A review of many commonly adopted frailty instruments in clinical practice has analysed their clinimetric properties (agreement, construct validity, responsiveness, interpretability, content validity, internal consistency, floor and ceiling effect). 42 Frailty instruments have mostly been validated as prognostic tools, but their ability for capturing interventioninduced changes in frailty over time is unclear. At the present time, and with caution, the FI calculated according to the deficit accumulation model 11, 12 appears, from the clinimetric standpoint, the most suitable and reliable to capture changes in frailty over time.
Using the frailty index as a tool to estimate the increase in healthcare resources required for different levels of frailty may help to identify the investment needed to reduce frailty in the community. 43, 44 Frailty in cardiology
With progressive population ageing, the burden of cardiovascular disease has become prevalent as a cause of mortality, morbidity and disability. 45 Therefore, there has been a recent surge of interest in evaluating frailty in patients with cardiovascular conditions. Frailty has been assessed in patients affected by various cardiovascular diseases, and many of the instruments adopted have demonstrated prognostic value; [46] [47] [48] they may have value in defining guidelines for cardiac patients' management during hospitalisation and after discharge. Each of the instruments proposed has its own grade of complexity and prognostic information. In general, even as a sole prognostic indicator and with the above limitations, instruments describing a frailty status in several populations of cardiac patients have outscored other more usually adopted prognostic indicators. [46] [47] [48] Frailty in elderly patients with acute coronary syndrome or percutaneous transluminal coronary angioplasty
Many studies have evaluated frailty in elderly patients after an acute coronary syndrome (ACS) or percutaneous transluminal coronary angioplasty (PTCA) by using several instruments, such as the phenotypic model (PFI), 4 the CSHA clinical frailty scale, 22 or the EFS. 23 In this setting frailty ranged from 10% to 48%, and higher levels of frailty were associated with worse outcomes (Table 5 ). 47, [49] [50] [51] [52] [53] [54] [55] These studies showed an independent added prognostic value of frailty assessment, and although larger studies are needed to refine risk prediction models, it is suggested that clinicians and researchers should consider how they can embed frailty measurement into clinical practice.
Frailty in elderly patients undergoing cardiac surgery
In the current era, the elderly represent the fastest growing group of patients referred for cardiac surgery, with the proportion of patients aged 75 years or older rising from 16% in 1990 to 25% in most recent estimates. 56 These complex and often frail patients are at increased risk of falls, prolonged hospitalisation and mortality after surgery. 56, 57 For this reason, many groups have evaluated preoperative frailty to increase prognostic capability. 56, 58, 59 Recently, Afilalo et al. 56 in a population of 152 elderly patients (>70 years) undergoing coronary artery bypass graft and/or valve surgery, evaluated the incremental prognostic value of four different frailty scales and of three disability scales compared with classic cardiac surgery risk scores. Frailty scales adopted in this study were the Fried frailty scale, 4 the expanded Fried frailty scale (addition of cognitive impairment and depressed mood), 60 the four-item MacArthur study of successful ageing frailty scale subdimensions (gait speed, handgrip strength, inactivity, cognitive impairment), 61 and gait speed alone. Compared with the Parsonnet score 62 or the Society of Thoracic Surgeons predicted risk of mortality or major morbidity score (STS-PROMM), 63 the addition of frailty and disability provided independent incremental value and improved model discrimination for in-hospital postoperative mortality or major morbidity. Thus, the integration of frailty, disability and risk scores should better characterise elderly patients referred for cardiac surgery and identify those who are at increased risk.
Transvalvular aortic valve replacement
Transvalvular aortic valve replacement (TAVR) is a successful intervention in elderly patients with aortic stenosis, and patients after TAVR benefit from CR despite their older age and clinical complexity and frailty. 64 Several studies have recently described the added prognostic value of frailty evaluation over standard criteria in elderly patients undergoing TAVR.
A modified Fried frailty score (gait speed, grip strength, serum albumin and activities of daily living) in very old patients was independently associated with increased one-year mortality after TAVR. 65 A frailty index based on the assessment of cognition, mobility, nutrition, BADL and IADL predicted functional decline after TAVR, suggesting that this index might identify elderly patients who could potentially benefit from additional geriatric interventions. 66 Another study reported that a multidimensional geriatric assessment-based score (including cognition, nutrition, mobility, BADL, plus a 'home-made' frailty index) predicted one-year mortality and major adverse cardiovascular and cerebral events (MACCE) after TAVR in patients aged over 70 years. 67 Recently, a PARTNER trial sub-study found that, in older recipients of TAVR, frailty, assessed using a modified frailty phenotype model (serum albumin, dominant handgrip strength, gait speed and activities of daily living), independently predicted all-cause mortality or poor outcome at one year. 68 A recent review of six studies and 4756 patients undergoing cardiac surgery or TAVR concluded that frail elderly patients have a higher likelihood of mortality, morbidity, functional decline and MACCE following cardiac surgery or TAVR, regardless of the frailty assessment tool. 69 All of the studies [65] [66] [67] [68] [69] have reported frailty measurement before surgery or intervention and utilised it as an added prognostic tool for later events, but none of these studies has evaluated frailty in the immediate postoperative period, which is usually unstable and therefore not well suited for measurements of frailty that require clinical stability.
Frailty in elderly patients with chronic heart failure/ left ventricular assist device
Frailty prevalence in chronic heart failure (CHF) patients ranges from 15% to 74%, depending on the population and assessment method. The FRAIL-HF study 70 reported that 70.2% of non-dependent older patients hospitalised for CHF are frail, as evaluated by the Fried criteria. In these patients a superimposition of primary frailty associated with progressive ageing and frailty secondary to CHF is difficult to disentangle, as both share similar physiopathological mechanisms, such as anabolic-catabolic and neurohormonal imbalance, systemic inflammation, increased oxidative stress or mitochondrial dysfunction. 71 In CHF frailty is consistently associated with poor outcome, quality of life, disability or hospitalisation. [72] [73] [74] [75] [76] [77] [78] [79] [80] McNallan et al. reported that frailty, measured by the Fried criteria, was an independent predictor of hospitalisations in community patients with CHF. 72 Cacciatore et al., utilising the Lachs frailty staging score (based on sensorial compromise, cognitive impairment, urinary incontinence, poor social support and disability), found that the probability of death in patients with CHF and a frailty score of 3 was 100% as compared with 55% in patients with CHF and a frailty score of 1. 73 Lupon et al. found that a scale based on evaluation of BADL-IADL, cognitive function, psychological and social status, was independently correlated with quality of life, hospitalisation and mortality. 74, 75 Volpato et al. 76 and Chiarantini et al., 77 utilising the short physical performance Battery (SPPB), a test measuring lower extremity physical performance by walking speed, balance test and ability to stand up from a chair, 78 found in patients hospitalised for CHF that poor SPPB scores at hospital discharge were predictive of a greater risk of rehospitalisation or death. Even single items such as low gait speed or low grip strength in community living CHF patients were correlated with hospitalisation at follow-up, 79 and the Barthel index of disability and cognitive compromise correlated with six months mortality in CHF patients admitted to hospital. 80 Recently, Dunlay et al. found, in a small cohort study of advanced CHF patients undergoing left ventricular assist device (LVAD) implantation, that pre-intervention frailty was associated with increased mortality. 81 This suggests that frailty assessment may be relevant for identifying suitable candidates for this invasive procedure. There is evidence that LVAD intervention 82 and heart transplantation 83 improve some biological, structural and functional markers of frailty associated with CHF.
Frailty and CR
Despite the negative bias for referring very elderly patients with complex comorbidities and frailty to CR, 84 at present patients older than 75 years represent about one third of those referred to CR. 85 Thus frailty might be present in a substantial proportion of patients admitted to CR, and this condition needs specific consideration.
The prevalence of frailty and its clinical and prognostic relevance has not as yet been well characterised in the environment of CR, although many studies have reported the measurement of frailty in patients with coronary syndromes in intensive care units or in cardiology wards, [49] [50] [51] [52] and others have underscored the close link between frailty and CHF. [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] As patients after ACS or CHF represent a considerable proportion of those participating in CR, 85, 86 we may suggest that frailty measurement should be performed in CR, to help plan their management and estimate their prognosis.
Frailty complicates the management of elderly patients, because it may affect the type and timing of diagnostic procedures and pharmacological and nonpharmacological treatment. Baseline physical function evaluation should be tailored to their physical conditions, and the CR programme should be individualized on the basis of their functional compromise and disability. 87 Pharmacological treatment should be carefully weighted, balancing guideline recommendations with a prudent approach, because associated comorbidities may increase iatrogenic complications. In community living or institutionalised frail elderly patients tailored exercise training has improved to some degree their physical function and quality of life. [88] [89] [90] [91] [92] [93] Individuals at higher risk of disability at baseline derive the most benefit from these types of interventions 90 by increasing gait speed, improving balance and performance in activities of daily life, 91 or SPPB. 92 However, it is still uncertain whether these positive results can be applied to CR patients. Particularly in patients with CHF, structured exercise training improves the neurohormonal, inflammatory and metabolic parameters of CHFrelated frailty and has favourable effects on physical function, functional capacity and quality of life. 70 It is still uncertain whether therapeutic interventions (pharmacological and non-pharmacological) that have proved successful in younger CHF patients will be successful in elderly patients, because the majority of randomised clinical trials in CHF do not include very elderly patients with frailty. However, from a practical standpoint, exercise-based CR programmes should be implemented, with caution, aimed at obtaining improvement in physical mobility, functional capacity, fall prevention, disability prevention or decreased progression, and improvement in quality of life.
Nutrition is also a very important part of the multidimensional intervention in CR, 94 particularly in very elderly and frail or sarcopenic/cachectic patients, where a poor nutritional status is one of the main Table 6 . Recommended tools for frailty evaluation in cardiac rehabilitation.
Tool
Items Reference
Edmonton frailty scale 17 Simple questions or tasks, assessing cognition, self-perceived health, dependence for ADL, social support, medication use, nutrition, mood, continence and functional performance. Each item is given from 0 to 2 points, and a frailty state is assigned to a global score >8/17.
23
Clinical frailty scale from the CSHA study Frailty assessment tool in the domains of mobility, energy, physical activity and function. Scale ranging from a level of 1 (very fit) to 8 (very severely frail).
22
pathophysiological mechanisms for frailty. Recent studies suggest that improving nutritional status may reduce the risk of frailty. 95, 96 Furthermore, a recent review has shown that nutrition may improve the functional outcome of elderly and frail patients. 97 
Future directions
Step 1: Feasibility of frailty measurement in the setting of cardiac rehabilitation Assessment of frailty in the CR requires additional time within routine clinical evaluation. While the addition of frailty tools to the management of the elderly patient holds promise, multiple topics should be clarified before recommending their widespread clinical application. These include identifying which of the many tools provides the best combination of performance and facility, with clear definition of standardised values.
A variety of instruments for measuring frailty could be tested in CR and compared regarding their practical feasibility, trying to achieve a compromise between simplicity of administration and completeness of frailty domain representation. It is important to stress that the proposed tools should be selected among those already validated in hospitalised patients with cardiovascular disease, and particularly in patients after an acute coronary event or with CHF, who are likely to be similar to those admitted to CR programmes. It is uncertain whether tools validated before the index event for CR or in other clinical settins may be applicable to patients after a cardiovascular acute event/ intervention.
The EFS could be used as representative of a userfriendly but comprehensive instrument (see also Table  6 ). 23 The EFS is easy to administer, requiring less than 5 minutes to perform; it can be administered by any professional (nurse, technician) or student, and it has been validated in elderly patients after acute coronary syndromes, 49 where it was found to correlate with prognosis. It also includes two clinical performance items interrogating cognition (clock test) and functional performance (timed up and go -TUG test). Tools based on the deficit accumulation model, such as the 40-item FI adopted by Singh et al. 98 adopted in elderly patients in acute geriatric rehabilitation wards, could be used to assess prognosis or guide intervention planning, or for evaluating frailty changes with time; however, in the busy CR world tools based on the deficit accumulation model may be cumbersome to apply. Therefore, an easy-to-use tool based on a standardised subjective evaluation of frailty would be more easily accepted and adopted, such as the Canadian Study on Health and Ageing clinical frailty scale 22 (Table 6 ).
The authors, through the European Association of Preventive Cardiology (EAPC), seek to evaluate the feasibility of applying these or more tools in CR centres through a European registry study in all elderly patients aged over 75 years. This would have the advantage of familiarising the cardiologist working in CR with frailty instruments, while screening for the frequency of frail elderly patients enrolled in European cardiac rehabilitation centres.
Some practical points should be discussed, such as who carries out these measurements. It is the authors' opinion that, due to the simple nature of the data to be collected, any health professional (cardiologist, cardiologist in training, nurse, allied health professional or medical student) could perform a frailty measurement, provided a uniform method of data collection is agreed and shared within and between CR centres.
The timing of frailty assessment in CR is also relevant. It is the authors' opinion that frailty should be measured at admission to CR if the patient is already stable, or later as soon as clinical stability is reached in the course of the rehabilitative programme. We believe that this approach is more correct, because before the acute event or surgery a frailty status may be worsened by the severity of disease, and may improve after clinical stabilisation is reached in CR. On the other hand, in patients entering CR after cardiac surgery, surgical complications in addition to a pre-surgical disability may limit their function, and it would be wise to wait for a progressive improvement in physical function before screening patients for frailty.
Step 2: Frailty and prognosis
It is still uncertain whether the addition of any frailty score/index to routine assessments in elderly patients entering CR may increase the prognostic capacity in that setting.
Therefore, these instruments should be tested in the CR environment as prognostic indicators against clearly defined endpoints, such as hospitalisation length, quality of life, disability and compared to traditional prognostic indicators, such as left ventricular ejection fraction, myocardial ischemia, arrhytmias or functional capacity. In this regard, a prospective observational study could be proposed for CR centres in Europe to evaluate the prognostic ability of frailty tools. If this is successful, CR practitioners may acquire an added tool to improve the prediction of outcomes, and be able to tailor the type and intensity of interventions for frail patients better.
In conclusion, it is the opinion of the authors that lead CR practitioners should work together with geriatricians to become more familiar with frailty instruments and their application in the clinical environment in very elderly patients, to improve their prognostic ability and to design specific tailored interventions in complex patients. Further large studies can then be undertaken, to determine if the use of frailty measurement improves outcomes for elderly and frail patients admitted to CR.
Key messages
. Frailty is a condition specifically present in the elderly population, characterised by declining function of multiple physiological systems associated with loss of physiological reserves. . Two main models are proposed for frailty: the phenotypic model (primary frailty) or the deficits accumulation model (secondary frailty). . Different instruments have been used to measure frailty. . Frailty correlates to medical outcomes in the elderly, independently of how it is measured. . Frailty has been shown to have prognostic value for patients with coronary artery disease, cardiac surgery, TAVR, CHF and LVAD. . The prevalence, clinical and prognostic relevance of frailty in a CR environment has not yet been well characterized. . The presence and severity of frailty may modulate the CR programme through tailored interventions. . We need to understand better to what extent CR may change the course and the prognosis of frailty, especially in cardiovascular patients, because exercise training and nutrition are well-known cornerstones in the management of elderly cardiac patients.
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